However, in two meta-analyses enrolling more RCTs/quasi-RCTs that compared early or late EPO with placebo or no intervention, late EPO brought about a trend of increased risk for ROP [332], while early EPO had no impact [333]. The gene discussed is EPO; the disease is retinopathy of prematurity.